•
Dec 31, 2021

IGM Biosciences Q4 2021 Earnings Report

EPS
-$1.5
Previous year: -$0.79
+89.9%
Cash and Equivalents
$133M
Previous year: $241M
-44.7%
Free Cash Flow
-$36.7M
Previous year: -$29.5M
+24.4%
Total Assets
$298M
Previous year: $409M
-27.0%

IGM Biosciences

IGM Biosciences